ROCKVILLE, MD -- (MARKET WIRE) -- 06/28/10 -- MarketResearch.com has announced the addition of Kalorama Information's new report "World Pharmaceutical and Biopharmaceutical Market, 2010-2015 (Pipeline Analysis of the Top 50 Companies)," to their collection of Biopharmaceuticals market reports. For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2691449

This research undertaking is the result of a detailed analysis of the late stage R&D pipeline of the 50 top companies in pharmaceuticals, the companies that produce the lion's share of revenues. While the report looks at the entire pipeline to 2015, a key focus of the report is the increasing role of biopharmaceutical products. The growing interest in biotechnology development has transitioned the pharmaceutical industry to biopharmaceuticals in less than a decade. Companies such as Pfizer, Merck and Novartis have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts.

Companies such as Amgen and Genzyme, which specialize in biotechnology, are now competing with a growing number of companies and the lines between pharmaceutical and biotechnology specialty companies are becoming more blended; which is a trend expected to continue to grow.

This research report captures these trends, extracting sales for all pharmaceutical and biopharmaceutical products (excluding prophylactic vaccines) and providing estimates and forecasts of the world biopharma market.

The line between pharmaceutical companies and biopharmaceutical companies is blurred to the point of no longer being a distinct. Among the top companies in biopharmaceuticals are, not surprisingly, the same names that have dominated pharmaceuticals for years -- Pfizer, Merck and Novartis. These companies have been unable to ignore the benefits of investing in biotechnology and have focused on a pipeline in this direction through strategic acquisitions and partnerships with biotech companies and/or through their own in-house research efforts. Specialist companies such as Amgen and Genzyme are now competing with a growing number of companies. Increased activity in the research and development departments of major pharmaceutical companies in recent years, activity that we believe will have near-term market impact.

Biopharmaceuticals are defined as any substance produced by natural organisms or recombinant techniques consisting of proteins and other products derived from living organisms for the treatment or management of diseases or injuries. Biopharmaceuticals are created through fermentation, recombinant DNA technology, and other bioprocesses.

The complex nature of biopharmaceuticals and the growing interest in development of these products has resulted in a flood of new issues affecting the already complicated healthcare market. There are a number of issues and trends which are experienced by the healthcare industry as a whole and others which are unique to biopharmaceuticals, their development and commercialization.

Topics covered in the report include...

• Biotechnology Drug Development
• Orphan Drugs
• Fast Track Drug Status
• Other Accelerated Methods for Drug Approval
• Pharmaceutical Regulatory Exclusivity
• Biosimilar Development
• Aging Populations
• Mergers, Acquisitions, and Collaborations
• Contributors to R&D Success
• R&D Spending Trends
• The Role of Contract Research Organizations
• Sustainability in a Changing Pharmaceutical Industry
• Market Estimates by Major Drug Category, including:
  
  
  • Cardiovascular/Blood
  • Neurotherapeutics
  • Infection
  • Oncology
  • Respiratory/Inflammatory
  • Gastrointestinal
  • Other
    
    
• Discussion of Marketplace Trends
• Pipeline Analysis of Major Pharmacos
• Detailed Company Profiles
• Comparison of Market at Current Growth Versus Impact of Late-Stage Products
• Biopharmaceutical Market Breakdown
• Best-Selling Biopharmaceutical Products
• Regulatory Activity and Market Impact

For more information, visit http://www.marketresearch.com/product/display.asp?ProductID=2691449.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Sean Snyder
MarketResearch.com
ssnyder@marketresearch.com
240.747.3076